abstract |
Cloning and expression of nucleotide DNA segments encoding bovine I-1B, and processes for producing purified bovine IL-1B as a product of recombinant cell culture, are disclosed. In addition methods directed to vaccines and treatment of bovine wounds, where IL-1B containing compositions are used as the active ingredient, are also disclosed. |